A large population based case-cohort study in the United Kingdom (UK) also failed to observe an association between the common CYP2D6*4 variant and breast cancer specific survival, however, they did note that the null CYP2D6*6 allele may affect survival in patients taking tamoxifen [82]. This evidence concerns the gene CYP2D6 and breast cancer.